In this regard, the stimulation of Nrf2-ARE signaling pathways in the brain has been considered as one of the major pharmaceutical strategies for the treatment and prevention of neurodegenerative disease and brain aging. This evidence concerns the gene NFE2L2 and neurodegenerative disease.